Aspirin and Antiretroviral Therapy in HIV Infected Patients
The Effect of Aspirin and Antiretroviral Therapy on Cardiovascular Risk in HIV Infected Patients: A Pilot Study
Sponsor: Hennepin Healthcare Research Institute
Terminated
Lack of funding
Other terminated trials from Hennepin Healthcare Research Institute
- Continuous Glucose Monitoring · Phase NA · Sep 2021
- Abdominal Pain · Phase PHASE4 · Jun 2021
- Diabetes Mellitus · Phase NA · Sep 2020
- Agitation,Psychomotor · Jul 2018
- HIV Infections · Phase PHASE4 · Dec 2011
See all terminations from Hennepin Healthcare Research Institute
Other HIV Infection trials with similar outcome
Listed as NCT00783614, this PHASE2 trial focuses on HIV Infection and remains terminated or withdrawn. Sponsored by Hennepin Healthcare Research Institute, it has been updated 12 times since 2008, reflecting substantial change activity. This study is part of the global effort to build evidence for infectious disease interventions.
Status Flow
Change History
12 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Terminated PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Terminated PHASE2
-
Dec 2021 — Dec 2022 [monthly]
Terminated PHASE2
▶ Show 7 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Terminated PHASE2
-
Apr 2020 — Jan 2021 [monthly]
Terminated PHASE2
-
May 2019 — Apr 2020 [monthly]
Terminated PHASE2
-
Jun 2018 — May 2019 [monthly]
Terminated PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Terminated PHASE2
-
Feb 2017 — Dec 2017 [monthly]
Terminated PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Terminated PHASE2
First recorded
Oct 2008
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hennepin Healthcare Research Institute
For direct contact, visit the study record on ClinicalTrials.gov .